all report title image

Metoprolol Tartrate Market, By Route Of Administration (Oral, Injectable), By Application (Hypertension, Cardiovascular, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In : 30 Mar, 2026
  • Code : CMI5256
  • Pages :152
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Metoprolol Tartrate is a selective β1 receptor blocker medication that is designed for the treatment of cardiovascular diseases and hypertension, as it works as slowing down the heart rate and makes the heart more efficient at pumping blood around the body. It is used for treating high blood pressure issues, chest pain due to low blood circulation to the heart, and abnormal heart rate. Metoprolol Tartrate is mostly used in the treatment of Angina pectoris, Cardiac arrhythmias, and thyrotoxicosis. Metoprolol Tartrate is available in two types of formulations including oral and injectable. The generic form of Metoprolol Tartrate is Lopressor. Metoprolol comes in form of immediate-release tablets which are designed to disintegrate and release medicine and extended-release tablets and it is prescribed medicine only.

Market Dynamics

Increasing prevalence of cardiovascular diseases in various region is expected to drive the global metoprolol tartrate market over the forecast period. For instance, in August 2021, European statistics published data on cardiovascular diseases, stating that in the year 2019, approximately 45,400 bypass surgeries were conducted in Germany. Moreover, in the year 2016, 1.68 million deaths occurred due to cardiovascular diseases in the Europe region. The same data on prevalence of cardiovascular diseases reported that high blood pressure increased in age group from 25 to 34 years and that around 3.4% of the population between this age group in Europe was reported to have hypertensive diseases. Furthermore, more than 54.6% population of hypertension diseases were aged 75 years or older, which is expected to drive demand for metoprolol tartrate in upcoming years.

Key features of the study

  • This report provides an in-depth analysis of the global metoprolol tartrate market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global metoprolol tartrate market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Novartis Pharmaceuticals Canada Inc., AstraZeneca Pharma India Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Inc., CTX Life Sciences Pvt. Ltd., Hikma Pharmaceuticals PLC, Validus Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Aurobindo Pharma USA, Sandoz Canada Inc., Apotex Inc., Ipca Laboratories Ltd, and Rubicon Research Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global metoprolol tartrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global metoprolol tartrate market.

Market Segmentation

  • By Route of administration
    • Oral
    • Injectable
  • By Application
    • Hypertension
    • Cardiovascular
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East & Africa
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa
  • Key Players
    • Novartis Pharmaceuticals Canada Inc.
    • AstraZeneca Pharma India Limited
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Reddy’s Laboratories Ltd.
    • Sun Pharmaceutical Industries Inc.
    • CTX Life Sciences Pvt. Ltd.
    • Hikma Pharmaceuticals PLC
    • Validus Pharmaceuticals LLC
    • Alembic Pharmaceuticals Limited
    • Aurobindo Pharma USA
    • Sandoz Canada Inc.
    • Apotex Inc.
    • Ipca Laboratories Ltd
    • Rubicon Research Pvt. Ltd.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. Global Metoprolol Tartrate Market, By Route of Administration, 2026 – 2033, (USD Bn)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
  5. Global Metoprolol Tartrate Market, By Application, 2026 – 2033, (USD Bn)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
  6. Global Metoprolol Tartrate Market, By Distribution Channel, 2026 – 2033, (USD Bn)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn) 
  7. Global Metoprolol Tartrate Market, By Region, 2026 – 2033, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2026–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Novartis Pharmaceuticals Canada Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • AstraZeneca Pharma India Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Dr. Reddy’s Laboratories Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sun Pharmaceutical Industries Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • CTX Life Sciences Pvt. Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Hikma Pharmaceuticals PLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Validus Pharmaceuticals LLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Alembic Pharmaceuticals Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Aurobindo Pharma USA
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sandoz Canada Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Apotex Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Ipca Laboratories Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Rubicon Research Pvt. Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.